Ovulation induction drug therapy for anovulatory infertility associated with polycystic ovary syndrome

Printer-friendly version

Presents a systematic review and critical appraisal of the evidence on the use of ovulation induction (OI) drug therapy to manage anovulatory infertility associated with polycystic ovary syndrome (PCOS) in women of reproductive age. Provides the current published scientific evidence about its safety and efficacy/effectiveness in terms of pregnancy rate in this category of infertile patients.